We have developed a fast, simple, and consistent method to generate valuable primary human vascular stem cells from a small, easily obtained sample of human umbilical cord blood.
Fusion Antibodies is dedicated to the discovery and early development of antibodies to help bring about a positive change in the healthcare industry.
Sengenia was founded over a decade ago and is solely focused on bringing innovative sensing solutions to a wide range of sectors.